The aim of our study was to assess the safety and efficacy of a CyA-to-tacrolimus conversion in a group of 14 renal transplant recipients with histology-proven CAN. Serum creatinine levels, proteinuria, and the incidence of drug side effects were monitored over a period of 1 year following CyA-to-tacrolimus conversion
Planned conversion from tacrolimus to sirolimus was evaluated in de novo kidney transplant recipient...
The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-ind...
Background and objectives Calcineurin inhibitors, while representing advances for solid organ transp...
Long-term use of cyclosporine after renal transplantation results in nephrotoxicity and an increased...
Long-term use of cyclosporine after renal transplantation results in nephrotoxicity and an increased...
In pediatric kidney transplant recipients, tacrolimus has been proposed either for primary immunosup...
To evaluate the role of tacrolimus in the treatment of Chronic Graft Nephropathy (CGN), a pilot cros...
Cyclosporine is considered to contribute to the high cardiovascular morbidity and mortality in patie...
Cyclosporine is considered to contribute to the high cardiovascular morbidity and mortality in patie...
BACKGROUND: The aim of this study is to evaluate the effects of RAPA conversion in patients undergoi...
Background. Tacrolimus and cyclosporine might have different effects onintra-renal fibrosis and allo...
Background. Tacrolimus and ciclosporin might have different effects on intra-renal fibrosis and allo...
Maintenance immunosuppression with calcineurin inhibitors (CNI) following renal transplantation is a...
BACKGROUND: Though cyclosporine has dramatically decreased rejection rates and improved graft surviv...
BACKGROUND: Cardiovascular disease is a major cause of morbidity and mortality in renal recipients. ...
Planned conversion from tacrolimus to sirolimus was evaluated in de novo kidney transplant recipient...
The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-ind...
Background and objectives Calcineurin inhibitors, while representing advances for solid organ transp...
Long-term use of cyclosporine after renal transplantation results in nephrotoxicity and an increased...
Long-term use of cyclosporine after renal transplantation results in nephrotoxicity and an increased...
In pediatric kidney transplant recipients, tacrolimus has been proposed either for primary immunosup...
To evaluate the role of tacrolimus in the treatment of Chronic Graft Nephropathy (CGN), a pilot cros...
Cyclosporine is considered to contribute to the high cardiovascular morbidity and mortality in patie...
Cyclosporine is considered to contribute to the high cardiovascular morbidity and mortality in patie...
BACKGROUND: The aim of this study is to evaluate the effects of RAPA conversion in patients undergoi...
Background. Tacrolimus and cyclosporine might have different effects onintra-renal fibrosis and allo...
Background. Tacrolimus and ciclosporin might have different effects on intra-renal fibrosis and allo...
Maintenance immunosuppression with calcineurin inhibitors (CNI) following renal transplantation is a...
BACKGROUND: Though cyclosporine has dramatically decreased rejection rates and improved graft surviv...
BACKGROUND: Cardiovascular disease is a major cause of morbidity and mortality in renal recipients. ...
Planned conversion from tacrolimus to sirolimus was evaluated in de novo kidney transplant recipient...
The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-ind...
Background and objectives Calcineurin inhibitors, while representing advances for solid organ transp...
DOI
Add to ORKG